Find News

Filter articles

Applied Filters

Showing 1 to 10 of 2241 results

Roche unit wins Fed Circ clash over blood clot treatment

US21-09-2023Legal developmentsMuireann Bolger

Long-running legal dispute tackles questions of enablement and ‘undue experimentation’ | Federal Circuit says it is bound by SCOTUS’ findings in Amgen v Sanofi.

Natera files patent lawsuit over DNA technology

US01-08-2023Marisa Woutersen

The lawsuit alleged the unlawful use of cfDNA technology in RaDaR assay and related products | Adds to an existing legal action the company filed against Inivata.

US court resolves muscle relaxant dispute by enforcing arbitration award

Switzerland, US20-07-2023Marisa Woutersen

Polpharma’s injunction bid fails as motion is dismissed with prejudice | Court upholds Swiss Arbitration process.

Medtronic faces patent review revival as Fed Cir faults PTAB

US11-07-2023Muireann Bolger

Precedential decision marks blow for medical device maker after earlier win | PTAB criticised for “fundamental legal error” and “narrow definition”.

Dechert hires Harvard-educated chemist as IP partner

US11-07-2023Marisa Woutersen

John Rearick is the latest addition to the firm to strengthen its life sciences practice.

FTC wades into Medtronic bipolar energy case

US05-07-2023Muireann Bolger

Commission says that medical device maker’s arguments have broad implications for antitrust enforcement | Dispute concerns alleged exclusive-dealing and bundling arrangements.

FTC weighs in on AbbVie antitrust litigation

US22-06-2023Muireann Bolger

Commission argues that a New York federal court erred in its finding that deals between an AbbVie unit and generic manufacturers were justified | US Supreme Court previously ruled that “unjustified” reverse payments can violate the antitrust laws.

Bausch targets Israeli firm in skin treatment dispute

US22-06-2023Muireann Bolger

Pharma company claims infringement of both patents that cover the blockbuster treatment | Generic version has been in motion since May last year.

AbbVie unit sues Chinese rival over blood cancer drug

China, US20-06-2023Muireann Bolger

Both drug treatments inhibit a protein called Bruton’s tyrosine kinase that can trigger cancer | Lawsuit comes in wake of patent grant for disputed drug | New study caused headaches for AbbVie’s subsidiary.

Showing 1 to 10 of 2241 results